Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2024

European Healthtech startup funding raised during H1 2024.

In H1 2024, 222 European Healthtech companies closed 223 funding rounds and raised €2.2B in equity funding (excluding debt and grants), down 17.0% versus H1 2023. Debt rounds added €43M. UK led by capital raised, and The Future of Health Grant (FoHG) program was the most active investor. Data as of 20 Nov 2026.

Equity funding
€2.2B
-17.0% vs H1 2023 · excl. debt & grants · +€43M debt
Funding rounds
223
-27.8% vs H1 2023
Companies
222
Top country
UK
Rank among sectors
#7
4.6% of sector funding
Debt financing
€43M
1.9% of total
Top-10 round share
45.3%
of disclosed capital
Rounds ≥ €100M
2

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2024 — interactive chart.
Data table
FundingRounds
Jan€423M39
Feb€328M56
Mar€216M29
Apr€257M36
May€862M36
Jun€214M27

Top countries

by € raised
Healthtech — top countries by capital, H1 2024 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2024
UK€942M
Switzerland€367M
Germany€250M
France€210M
Finland€122M
Italy€112M
Netherlands€68M
Sweden€65M

Stage mix

by € raised
Healthtech — stage mix, H1 2024 — interactive chart.
Data table
Healthtech — stage mix, H1 2024
Other€1.1B
Series B€393M
Series C€270M
Series A€178M
Seed€160M
Series D+€99M
Debt€43M
Growth/Late€32M
Grant€18M
Pre-Seed€12M

Exits & M&A

20 Acquisition · 2 Merger

22 exits · €523M disclosed.

Calypso BiotechAcquisitionJan 2024€425M
SonioAcquisitionMay 2024€86M
ApoteaAcquisitionJan 2024€12M

Top deals

largest disclosed rounds in H1 2024
CompanyStageDateAmount
Bicycle TherapeuticsOtherMay 2024€512M
MMISeries CFeb 2024€102M
iOncturaSeries BJun 2024€80M
TimelineSeries D+Jan 2024€61M
OculisOtherApr 2024€55M
Infinite Roots (Mushlabs)Series BJan 2024€53M
Natural CyclesSeries CMay 2024€51M
UromemsSeries CJun 2024€44M
Grey Wolf TherapeuticsSeries BMay 2024€42M
LabGeniusOtherMay 2024€41M
Bob WSeries BFeb 2024€40M
PhagenesisSeries D+Mar 2024€39M
EniferSeries BMay 2024€36M
Relation TherapeuticsSeedMar 2024€32M
Enterprise TherapeuticsSeries BJan 2024€30M

Top investors

most active in H1 2024, by deal count